Sun Healthcare Group, Inc. (SUNH) Tops Q2 EPS by 1c; Withdraws Guidance

Sun Healthcare Group, Inc. (NASDAQ: SUNH) reported Q2 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $457.1 million versus the consensus estimate of $465.81 million.

The Company filed its definitive proxy statement concerning the transaction with Genesis HealthCare with the Securities and Exchange Commission on July 24, 2012. The Company has commenced mailing the proxy statement to stockholders of the Company and will hold a special stockholders meeting concerning the transaction on September 5, 2012. As previously announced, the closing is expected to occur in the fall. In connection with the transaction, the Company incurred $1.8 million of transaction costs through the six months ended June 30, 2012, which were primarily comprised of legal fees and financial advisory fees. Due to the pending transaction with Genesis HealthCare, the Company is withdrawing its 2012 financial guidance. As previously announced, the Company will not hold a quarterly conference call to discuss its second-quarter results.

For earnings history and earnings-related data on Sun Healthcare Group, Inc. (SUNH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Equity Partners II Inc (SECZ) Reports Q2 Loss of $2.37
• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance